| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |